Classification of Drugs to Treat Multidrug-Resistant Tuberculosis (MDR-TB): Evidence and Perspectives

Journal of Thoracic Disease - Hong Kong
doi 10.21037/jtd.2016.10.14
Full Text
Abstract

Available in full text

Date
Authors
Publisher

AME Publishing Company

Related search

Case Report: Multidrug-Resistant Tuberculosis (MDR TB)

Review of Primary Care Practice and Education (Kajian Praktik dan Pendidikan Layanan Primer)
2018English

Karakteristik Pasien Multidrug Resistant Tuberculosis (MDR-TB) Di RSUD Makassar

Jurnal Penelitian Kesehatan "SUARA FORIKES" (Journal of Health Research "Forikes Voice")
2019English

Pre-Extensively Drug Resistant Tuberculosis (Pre-XDR-Tb) Among Pulmonary Multidrug Resistant Tuberculosis (MDR-TB) Patients in Bangladesh

Journal of Tuberculosis Research
2018English

Pyrido[1,2-A]benzimidazole-Based Agents Active Against Tuberculosis (TB), Multidrug-Resistant (MDR) TB and Extensively Drug-Resistant (XDR) TB

ChemMedChem
Organic ChemistryMolecular MedicinePharmacologyBiochemistryToxicologyDrug DiscoveryPharmaceutics
2011English

New Drugs to Treat Multidrug-Resistant Tuberculosis: The Case for Bedaquiline

Therapeutics and Clinical Risk Management
2014English

Safety and Efficacy of Delamanid in the Treatment of Multidrug-Resistant Tuberculosis (MDR-TB)

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2013English

Second Line Drug Sensitivity Test of Multidrug Resistant Tuberculosis (MDR-TB) Isolates Using Proportional Method

Bayero Journal of Pure and Applied Sciences
2019English

Rising Trends of Multidrug Resistant (MDR) Tuberculosis in Pakistan

Biomedical Journal of Scientific & Technical Research
2018English

Factors Associated With Mortality Among Multidrug Resistant Tuberculosis MDR/RR-TB Patients in Democratic Republic of Congo

Journal of Tuberculosis Research
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy